Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
13.9M
-
Shares change
-
-2.25M
-
Total reported value, excl. options
-
$18.3M
-
Value change
-
-$8.26M
-
Number of buys
-
19
-
Number of sells
-
-36
-
Price
-
$1.32
Significant Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q2 2022
67 filings reported holding VINC - Vincerx Pharma, Inc. - Common Stock as of Q2 2022.
Vincerx Pharma, Inc. - Common Stock (VINC) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.9M shares
.
Largest 10 shareholders include Rubric Capital Management LP (2.11M shares), SAGE RHINO CAPITAL LLC (1.66M shares), Affinity Asset Advisors, LLC (1.37M shares), TANG CAPITAL MANAGEMENT LLC (1.03M shares), Long Focus Capital Management, LLC (980K shares), Rock Springs Capital Management LP (814K shares), Holocene Advisors, LP (758K shares), CITADEL ADVISORS LLC (624K shares), VANGUARD GROUP INC (579K shares), and SABBY MANAGEMENT, LLC (501K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.